Search research articles
Contact Us
Filters
Showing results (221-230 of 277) with videos related to
Page
of 28
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 23, 2011
Multifactorial approach to predicting resistance to anthracyclines
Christine Desmedt, Angelo Di Leo, Evandro de Azambuja, et al.
Seminars in Cancer Biology
|
October 13, 2017
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
Maria Vittoria Dieci, Nina Radosevic-Robin, Susan Fineberg, et al.
JCI Insight
|
December 21, 2018
Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagement
Douglas B Johnson, Mellissa J Nixon, Yu Wang, et al.
Nature Medicine
|
June 27, 2018
Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
Peter Savas, Balaji Virassamy, Chengzhong Ye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2019
Correction: RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors
Sherene Loi, Sathana Dushyanthen, Paul A Beavis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 2015
RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors
Sherene Loi, Sathana Dushyanthen, Paul A Beavis, et al.
Nature Medicine
|
August 24, 2018
Publisher Correction: Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
Peter Savas, Balaji Virassamy, Chengzhong Ye, et al.
Histopathology
|
April 21, 2026
World Health Organization classification of tumours of the breast 6th edition 2026
Cecily Quinn, Puay Hoon Tan, Kimberly H Allison, et al.
Journal of the National Cancer Institute
|
July 2, 2025
Stromal tumor infiltrating lymphocytes and TNBC-DX provide complementary prognostic information in triple-negative breast cancer
Shane R Stecklein, Miguel Martín, Guillermo Villacampa, et al.
Nature
|
March 22, 2019
Neoantigen-directed immune escape in lung cancer evolution
Rachel Rosenthal, Elizabeth Larose Cadieux, Roberto Salgado, et al.
Page
of 28
Search research articles
Search
Showing results (221-230 of 277) with videos related to
Sort By:
Page
of 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 23, 2011
Multifactorial approach to predicting resistance to anthracyclines
Christine Desmedt, Angelo Di Leo, Evandro de Azambuja, et al.
Seminars in Cancer Biology
|
October 13, 2017
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
Maria Vittoria Dieci, Nina Radosevic-Robin, Susan Fineberg, et al.
JCI Insight
|
December 21, 2018
Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagement
Douglas B Johnson, Mellissa J Nixon, Yu Wang, et al.
Nature Medicine
|
June 27, 2018
Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
Peter Savas, Balaji Virassamy, Chengzhong Ye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2019
Correction: RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors
Sherene Loi, Sathana Dushyanthen, Paul A Beavis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 2015
RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors
Sherene Loi, Sathana Dushyanthen, Paul A Beavis, et al.
Nature Medicine
|
August 24, 2018
Publisher Correction: Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
Peter Savas, Balaji Virassamy, Chengzhong Ye, et al.
Histopathology
|
April 21, 2026
World Health Organization classification of tumours of the breast 6th edition 2026
Cecily Quinn, Puay Hoon Tan, Kimberly H Allison, et al.
Journal of the National Cancer Institute
|
July 2, 2025
Stromal tumor infiltrating lymphocytes and TNBC-DX provide complementary prognostic information in triple-negative breast cancer
Shane R Stecklein, Miguel Martín, Guillermo Villacampa, et al.
Nature
|
March 22, 2019
Neoantigen-directed immune escape in lung cancer evolution
Rachel Rosenthal, Elizabeth Larose Cadieux, Roberto Salgado, et al.
Page
of 28